ClinicalTrials.gg
Not yet recruitingNCT06721780AR vs VRUpdated Dec 6, 2024

AR Vs VR in Burns Dressing Changes

An interventional study of Participants randomised to wear AR headset and Participants randomised to wear VR headset in Burns Multiple, sponsored by Buckinghamshire Healthcare NHS Trust. Not yet recruiting. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by Buckinghamshire Healthcare NHS Trust · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
4 Years to 17 Years
Sex
All
01

Study summary

For children with burn injuries, changing their dressings can be one of the most traumatising experiences of their treatment journey. This process is not only distressing for the children but also for their parents and the healthcare professionals involved. Current methods to reduce this trauma include the use of play therapists, but such resources are often limited. There is good evidence that Augmented Reality (AR) and Virtual Reality (VR) can help by providing a distracting and immersive environment that eases pain and fear. However, no studies have yet compared these two modern technologies to see which is more effective

02

Conditions studied

  • Burns Multiple

Browse trials for

03

In context

Burns

906 studies on the registry are indexed under Burns; 165 are open to participants now.

This study's planned enrollment of 90 is above the median of 40 across 664 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

Buckinghamshire Healthcare NHS Trust is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Participants presenting with guardians with parental responsibility, who are willing and able to consent to recruitment.

      • Aged 4-17 years
      • Presenting with burns requiring a dressing change, on their first attendance to the burns clinic.
      • Participating child is able to complete the FACES Pain Scale

Exclusion criteria

Exclusion Criteria:

    • Children aged 4 or below

      • Those with severe cognitive impairment, visual disorders, facial burns or other conditions preventing the safe use of VR/AR technology.
      • Previous 'cybersickness' symptoms (nausea, dizziness).
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • No intervention
    Standard care

    This is standard care (what they would normally receive if they were not enrolled into this study)

  • Active comparator
    Participants randomised to wear AR headset

    AR headset: MagicLeap 2 - running Divertini's "Watering Plants" world.

    Device: Participants randomised to wear AR headset

  • Active comparator
    Participants randomised to wear VR headset

    VR Headset: Oculus Quest 2 - Running SyncVR's Relaxation and Pain control simulations

    Device: Participants randomised to wear VR headset

Interventions

  • DeviceParticipants randomised to wear AR headset

    Participants will use an AR headset that employs a distraction game specifically designed for children and young adults undergoing painful procedures.

  • DeviceParticipants randomised to wear VR headset

    Participants will utilise a VR headset, running a calming virtual environment or an interactive game during the dressing change.

06

What researchers measure

Primary outcomes

  1. determine the relative performance

    To determine the relative performance of AR and VR in pain and anxiety control during burns dressings changes in comparison to standard of care. Objective measures: Pulse rate, Respiratory rate

    Time frame: 2 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2025; primary completion for Jan 2026, 11 months later.

Of 211 non-industry interventional studies with no phase under Burns, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 11 months is below that.

Counting every sponsor, half of 240 studies reached it within 15 months; a quarter within 6 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 26, 2024
First posted
Dec 6, 2024
StartEst.
Feb 2025
Primary completionEst.
Jan 2026
CompletionEst.
Feb 2026
Last update
Dec 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06721780
Lead sponsor
Buckinghamshire Healthcare NHS Trust
Responsible party
Sponsor
First posted
Dec 6, 2024
Start date
Feb 2025 (estimated)
Primary completion
Jan 2026 (estimated)
Completion
Feb 2026 (estimated)
Last update
Dec 6, 2024

Study contacts

Akshat Sawhney, MBBS BSc MRCS
Contact
bht.research@nhs.net
01296 831378
James Cooper, BSc, MSc
Contact
james.cooper9@nhs.net
07816020305

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion